08.07.12
Ingredion Incorporated has announced the results of a new independent clinical trial published in the Journal of Clinical Endocrinology & Metabolism, which showed that the consumption of HI-MAIZE resistant starch improves certain aspects of fatty acid metabolism within adipose (fat) tissue in study participants. These findings are significant because research has shown that impairment in fatty acid metabolism within fat cells can cause excess fat storage in muscles, liver and the pancreas, which directly causes insulin resistance, a major biomarker for prediabetes. The findings also help to explain how fat metabolism contributes to the development of prediabetes. Prediabetes is defined by the American Diabetes Association as blood glucose levels that are higher than normal, but not yet high enough to be diagnosed as diabetes. The US Centers for Disease Control has estimated that nearly 80 million American adults have prediabetes.
For further information: www.resistantstarch.com
For further information: www.resistantstarch.com